Sponsor or institution

Clinical trials and research at Gruppo Oncologico Italiano di Ricerca Clinica

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Early-Onset GI Cancer: From Tumor Features to Patient Habits

  This study tests how tumor biology and a patient’s lifestyle choices come together in people diagnosed with early-onset gastrointestinal cancer.

  Recruiting at 5 sites Gruppo Oncologico Italiano di Ricerca Clinica · Bologna, BO and 10 other locations · NCT07479472

• Reasons for recurrence after adjuvant osimertinib in surgically removed EGFR-mutated lung cancer

  This project looks for genetic and clinical reasons why people with EGFR-mutated lung cancer who had surgery and adjuvant osimertinib later had their cancer come back, using tissue and blood samples taken at recurrence.

  Recruiting Gruppo Oncologico Italiano di Ricerca Clinica · Bari, BA and 24 other locations · NCT07363252

• Tracking HER2 mutations and treatment patterns in advanced non-small cell lung cancer in Italy

  This project will see how people in Italy with advanced NSCLC and HER2 mutations are diagnosed and treated over a one-year follow-up period.

  Recruiting at 2 sites Gruppo Oncologico Italiano di Ricerca Clinica · Bari, BA and 21 other locations · NCT07356544

• Combining atezolizumab with chemotherapy for relapsed extensive-stage small cell lung cancer

  This study is testing if adding an immunotherapy drug called atezolizumab to standard chemotherapy can help people with relapsed extensive-stage small cell lung cancer live longer and feel better.

  Recruiting at 2 sites Phase 2 Gruppo Oncologico Italiano di Ricerca Clinica · Aviano (PN) and 24 other locations · NCT06663098

• Treatment for extensive stage extrapulmonary small cell carcinoma using durvalumab with chemotherapy

  This study is testing if a new combination of durvalumab with chemotherapy can help people with advanced extrapulmonary small cell carcinoma feel better and live longer.

  Recruiting Phase 2 Gruppo Oncologico Italiano di Ricerca Clinica · Reggio Emilia · NCT06464068

• Combination of durvalumab with chemotherapy for lung cancer

  This study is testing if a new combination of chemotherapy and a drug called durvalumab can help people with advanced lung cancer feel better and improve their treatment outcomes.

  Recruiting at 3 sites Phase 2 Gruppo Oncologico Italiano di Ricerca Clinica · Bologna, BO and 14 other locations · NCT06418087

• Atezolizumab treatment for patients with malignant pleural mesothelioma after surgery

  This study is testing if the drug atezolizumab can help prevent cancer from coming back in patients with malignant pleural mesothelioma after they've had surgery.

  Recruiting at 2 sites Phase 3 Gruppo Oncologico Italiano di Ricerca Clinica · Meldola, ITAòY and 18 other locations · NCT04996017

Quick answers

How many clinical trials run by Gruppo Oncologico Italiano di Ricerca Clinica are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Italy. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →